STXBP1 Associations Across Europe and Israel Raise Awareness for Rare Disease Month
Rare Disease Month, culminating in Rare Disease Day on February 28 this year, is an important time for the rare […]
Uncategorized
Uncategorized
FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy
The European STXBP1 Consortium (ESCO) is excited to share groundbreaking news in the quest for new treatments for STXBP1 disorders!
Uncategorized
Registration now open! The 2nd European STXBP1 Summit and Roundtable in Heidelberg, Germany, 8-11 October 2025
The 2025 STXBP1 Summit, hosted by the European STXBP1 Consortium (ESCO), takes place in Heidelberg, Germany. This event, scheduled from
Uncategorized
European STXBP1 Consortium Secures Funding to Monitor Disease Progression in 50 STXBP1 Patients
The European STXBP1 Consortium (ESCO) is thrilled to announce that it has secured the necessary funding to commence its large
Uncategorized
Successful Million Dollar Bike Ride for research of STXBP1-related disorders!
On Saturday June 8, 2024, Dutch and Belgian teams including members from the European STXBP1 Consortium successfully biked the European
Uncategorized
Million Dollar Bike Ride 2024: Belgium and the Netherlands race for rare disease research
Research teams from ESCO member institutes in the Netherlands and Belgium are preparing to participate in the European satellite event
Uncategorized
ESCO members convene in Antwerp, Belgium for Inaugural Kick-Off Event
Representatives from ESCO’s eight member countries convened in Antwerp, Belgium, on February 8th, marking the initiation of ESCO’s strategic endeavours
Uncategorized
ESCO consortium takes off with new funding and EMA application
AUMC and VU have worked together with industry to develop animal and human disease models for STXBP1-RD and to design